CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 3,786 shares at $55.62 ($210,577)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market sale General Counsel and Secretary sold 3,182 shares at $46.78 ($148,854)
- 4 Open-market sale Chief Executive Officer sold 10,020 shares at $46.78 ($468,736)
- 4 Open-market sale Chief Financial Officer sold 3,708 shares at $46.78 ($173,460)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 3,150 shares at $48.26 ($152,019)
Page 3 of 45 · 883 filings